BIANCA: A phase 2 study of the safety and efficacy of tisagenlecleucel in pediatric patients with relapsed/refractory mature B‐cell non-Hodgkin lymphoma Meeting Abstract


Authors: Minard‐Colin, V.; Burkhardt, B.; Maude, S.; Phillips, C.; Diaz de Heredia Rubio, C.; Laetsch, T. W.; Curran, K.; Newsome, S.; Murray, N.; Pacaud, L.; Buechner, J.
Abstract Title: BIANCA: A phase 2 study of the safety and efficacy of tisagenlecleucel in pediatric patients with relapsed/refractory mature B‐cell non-Hodgkin lymphoma
Meeting Title: 15th International Conference on Malignant Lymphoma
Journal Title: Hematological Oncology
Volume: 37
Issue: Suppl. 2
Meeting Dates: 2019 Jun 18-22
Meeting Location: Lugano, Switzerland
ISSN: 0278-0232
Publisher: Wiley Blackwell  
Date Published: 2019-06-01
Start Page: 558
End Page: 559
Language: English
ACCESSION: 136932755
DOI: 10.1002/hon.5_2632
PROVIDER: EBSCOhost
PROVIDER: cin20
PUBMED: 31187525
DOI/URL:
Notes: Meeting abstract: OT12 -- Accession Number: 136932755 -- Entry Date: In Process -- Revision Date: 20190617 -- Publication Type: Article -- Supplement Title: Jun2019 Supplement S1 -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: cin20
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kevin Joseph Curran
    144 Curran